Alpha-1 Antitrypsin Deficiency (AATD) Latest Advances

Find the Latest Research About Alpha-1 Antitrypsin Deficiency (AATD)

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4011 publications

Advances in orphan drug development for alpha-1 antitrypsin deficiency: a 2025 update from the FDA and EMA.

Advances in orphan drug development for alpha-1 antitrypsin deficiency: a 2025 update from the FDA and EMA.

Journal: Therapeutic advances in respiratory disease
Published: January 07, 2026

The mechanism of pathogenic α1-antitrypsin aggregation in the human liver.

The mechanism of pathogenic α1-antitrypsin aggregation in the human liver.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: November 13, 2025

Pediatric Liver Diseases: Next-Generation Therapies.

Pediatric Liver Diseases: Next-Generation Therapies.

Journal: Clinics in liver disease
Published: October 18, 2025

Pioglitazone reduces hepatic α-1 antitrypsin accumulation through autophagy and AMPK activation in α-1 antitrypsin-deficient mice.

Pioglitazone reduces hepatic α-1 antitrypsin accumulation through autophagy and AMPK activation in α-1 antitrypsin-deficient mice.

Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: September 29, 2025

Pulmonary rehabilitation and quality of life in alpha-1 antitrypsin deficiency: findings from a retrospective cohort study.

Pulmonary rehabilitation and quality of life in alpha-1 antitrypsin deficiency: findings from a retrospective cohort study.

Journal: Thorax
Published: September 18, 2025

Rare but relevant: Genetic liver disease in the general medical setting.

Rare but relevant: Genetic liver disease in the general medical setting.

Journal: Clinical medicine (London, England)
Published: September 03, 2025

Phenotypic Expression of Respiratory Diseases and Tailored Treatment in Patients with Intermediate Alpha-1 Antitrypsin Deficiency: Evidence from a Retrospective Analysis of a Selected Cohort of Patients.

Phenotypic Expression of Respiratory Diseases and Tailored Treatment in Patients with Intermediate Alpha-1 Antitrypsin Deficiency: Evidence from a Retrospective Analysis of a Selected Cohort of Patients.

Journal: Medicina (Kaunas, Lithuania)
Published: August 23, 2025

Applications of Artificial Intelligence in Alpha-1 Antitrypsin Deficiency: A Systematic Review from a Respiratory Medicine Perspective.

Applications of Artificial Intelligence in Alpha-1 Antitrypsin Deficiency: A Systematic Review from a Respiratory Medicine Perspective.

Journal: Medicina (Kaunas, Lithuania)
Published: August 12, 2025

Administrative coding for alpha-1 antitrypsin deficiency including the pi*ZZ phenotype is accurate in Sweden.

Administrative coding for alpha-1 antitrypsin deficiency including the pi*ZZ phenotype is accurate in Sweden.

Journal: Scandinavian journal of gastroenterology
Published: August 11, 2025

Alpha-1 antitrypsin in COVID-19 patients: a dual-center screening study in Malaysia.

Alpha-1 antitrypsin in COVID-19 patients: a dual-center screening study in Malaysia.

Journal: Annals of Saudi medicine
Published: August 03, 2025

A new SERPINA1 null allele of the PI*S-plus type: PI*Q0Tegueste.

A new SERPINA1 null allele of the PI*S-plus type: PI*Q0Tegueste.

Journal: Gene
Published: July 21, 2025

Distribution of SERPINA1 gene mutations in patients with spontaneous pneumothorax: A cross-sectional study from a tertiary chest diseases clinic in Turkiye.

Distribution of SERPINA1 gene mutations in patients with spontaneous pneumothorax: A cross-sectional study from a tertiary chest diseases clinic in Turkiye.

Journal: Medicine
Published: July 14, 2025
Showing 1-12 of 4,011

Last Updated: 02/24/2026